Next-Gen pVAD Innovation: Venstra Medical’s Breakthrough with CEO Martin Cook
In this MedTech Unboxed episode, host Steve Maxson speaks with Martin Cook, PhD, the “Blood Pump Guy” and CEO of Venstra Medical, about advancing percutaneous ventricular assist devices (pVADs).
Explore unmet needs in predicate pVADs like Impella (vascular issues, incomplete unloading, mobility limits) and how Venstra’s low-profile, full-flow platform—powered by “magical” nitinol—delivers complete ventricular unloading, 7+ L/min support, ambulation, and lower hemolysis via a collapsible 9-Fr design (with expertise from partners like Resolution Medical).
We discuss the $2B+ pVAD market growing 18% annually, ASAIO Journal preclinical results, landmark DanGer Shock trial, and future potential in cardiogenic shock + STEMI.